Longitudinal assessment of circulating fibroblast activation protein in systemic sclerosis-associated interstitial lung disease
In conclusion, cFAP does not seem useful as a biomarker in SSc-ILD. However, the association between cFAP and skin score deserves further investigation.
Authors
- Bo Broens
- Alexandre E. Voskuyl (ORCID: https://orcid.org/0000-0002-9699-1827)
- JanWillem Duitman (ORCID: https://orcid.org/0000-0003-4254-3380)
- Conny J. van der Laken (ORCID: https://orcid.org/0000-0002-9865-6213)
- Tamara Dekker
- Iris A. Simons (ORCID: https://orcid.org/0009-0007-9686-3167)
Institutions
- Amsterdam Neuroscience (NL)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Arthritis Research & Therapy
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1186/s13075-025-03656-y
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00